Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Healthcare | Small Cap
Health Score : 7.86Advanced Enzyme Technologies Ltd. shows a strong and robust financial profile, marked by exceptional strengths in key areas. The company's financial foundation is remarkably stable, as it operates with very little debt, which significantly lowers its financial risk. It is in a phase of excellent growth, with sales, profits, and earnings all increasing at a high rate. Furthermore, its profitability is outstanding, indicating it is very efficient at turning revenue into actual profit. The company has no trouble covering its interest payments and dividends. While its ability to meet short-term financial needs is strong, its operational efficiency presents a mixed picture. The company is not generating as much revenue from its assets and inventory as it could be, which is a key area of weakness. Overall, the company's excellent growth and profitability are very positive, though its operational efficiency is a point of concern.
Health Score : 7.86Advanced Enzyme Technologies Ltd. shows a strong and robust financial profile, marked by exceptional strengths in key areas. The company's financial foundation is remarkably stable, as it operates with very little debt, which significantly lowers its financial risk. It is in a phase of excellent growth, with sales, profits, and earnings all increasing at a high rate. Furthermore, its profitability is outstanding, indicating it is very efficient at turning revenue into actual profit. The company has no trouble covering its interest payments and dividends. While its ability to meet short-term financial needs is strong, its operational efficiency presents a mixed picture. The company is not generating as much revenue from its assets and inventory as it could be, which is a key area of weakness. Overall, the company's excellent growth and profitability are very positive, though its operational efficiency is a point of concern.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
25.09
Industry Median
7.70
Small Cap Median
7.70
P/E RATIO
19.60
P/B RATIO
2.02
Industry Median
1.53
Small Cap Median
1.53
P/S RATIO
4.56
Industry Median
3.62
Small Cap Median
3.62
Others
PEG RATIO
6.81
EV/EBITDA RATIO
11.98
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹295.35 as on Sep 1, 2026.
Growth Score : 10.00The company is experiencing an excellent phase of growth. It is expanding strongly across all key areas, including revenue, operating profit, and net income. This indicates a high demand for its offerings and successful execution of its business strategy. The consistent growth in its asset base further suggests it is investing to support future expansion. This robust growth trajectory paints a very positive picture for the company's future prospects.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 5.38 | 2.27 | 15.34 | 2.08 | 17.11 |
| Operating Profit Growth Rate | -12.5 | -22.17 | 30.38 | -4.85 | 16.84 |
| Earnings Per Share (EPS) Growth | -18.26 | -11.68 | 26.14 | -1.68 | 28.58 |
| Asset Growth Rate | 9.95 | 11.98 | 7.8 | 5.92 | 14.15 |
| Net Income Growth Rate | -17.88 | -16.13 | 31.73 | -2.19 | 29.85 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Advanced Enzyme Technologies Ltd | 7.86 | 19.60 | Highly Overvalued | 229.00 | 11.77 | 174.00 |
| 2 | Panacea Biotec Ltd | 5.61 | -444.20 | Neutral | -5.00 | -4.88 | -7.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Quarterly Report⬤9th May 26
Statement Of Audited Consolidated Financial Results For The Quarter And Year Ended 31 March 20
UNDEFINED SENTIMENT
Quarterly Report⬤31st Jan 26
Quarterly Financial Results Q3 FY 2025-26
BULLISH SENTIMENT
Advanced Enzyme Technologies Ltd (AETL) is a leading Indian enzyme manufacturer. It specializes in researching, developing, producing, and marketing over 400 proprietary enzyme products. AETL caters to diverse industries including human nutrition, animal feed, textiles, food & beverages, and biofuels, focusing on sustainable and innovative biotechnology solutions with a significant global footprint.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Advanced Enzyme Technologies Ltd's P/E ratio (TTM) is 25.09, compared to the industry median of 7.70 and large cap median of 7.70.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Advanced Enzyme Technologies Ltd's P/B ratio is 2.02, compared to the industry median of 1.53 and large cap median of 1.53.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Advanced Enzyme Technologies Ltd's P/S ratio is 4.56, compared to the industry median of 3.62 and large cap median of 3.62.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Advanced Enzyme Technologies Ltd's PEG ratio is 6.81.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Advanced Enzyme Technologies Ltd's EV/EBITDA ratio is 11.98.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Advanced Enzyme Technologies Ltd's ROE is 10.66%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Advanced Enzyme Technologies Ltd's ROA is 12.45%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Advanced Enzyme Technologies Ltd's ROCE is 14%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Advanced Enzyme Technologies Ltd's operating margin is 30.70%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Advanced Enzyme Technologies Ltd's net margin is 23.32%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Advanced Enzyme Technologies Ltd's current ratio is 2.72.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Advanced Enzyme Technologies Ltd's debt-to-equity ratio is 0.01.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Advanced Enzyme Technologies Ltd's interest coverage ratio is 78.67.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Advanced Enzyme Technologies Ltd's DPS is ₹1.36.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Advanced Enzyme Technologies Ltd's EPS is 28.58.
(Source line: "Ratios as of 25 Oct 2026, based on last traded price of ₹295.35. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1989
Headquarters: Thane, Maharashtra
Core Offerings: Human Nutrition Enzymes, Animal Nutrition Enzymes, Industrial Enzymes, Bio-processing Solutions
Stock Listing: NSE (ADVENZYMES), BSE (540025)
Promoter: Dr. Vasant Rathi and family
Founded in 1989 by Dr. Vasant Rathi, Advanced Enzyme Technologies Ltd began as a manufacturer of enzymes. It has since grown to become one of the largest enzyme companies in India, expanding its product portfolio and global presence. The company went public with an IPO in 2016 to fuel further growth and expansion into new markets and applications, becoming a globally recognized player in the enzyme industry.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Human Nutrition | ~50-55% | N/A (consolidated reporting) |
| Industrial Bioproducts | ~25-30% | N/A (consolidated reporting) |
| Animal Nutrition | ~15-20% | N/A (consolidated reporting) |
Human Nutrition: Focuses on digestive aids, probiotics, nutritional supplements, and therapeutic enzymes, targeting pharmaceuticals and nutraceuticals for human health.
Animal Nutrition: Offers enzymes for feed digestibility enhancement, growth promotion, and disease prevention in poultry, aquaculture, and livestock.
Industrial Bioproducts: Provides enzymes for diverse applications including textile processing, food & beverage (baking, brewing, dairy), waste water treatment, and biofuels.
Mr. C. L. Rathi (Managing Director & CEO) - A veteran in the enzyme industry with extensive experience in driving growth, innovation, and global expansion for the company.
Advanced Supplementary Technologies Corporation (USA)
Enzyme Innovation Inc. (USA)
JC Biotech Pvt. Ltd. (India)
Advanced Enzyme Far East (Hong Kong) Ltd.
Advanced Enzymes Europe B.V. (Netherlands)
No major recent bonus/rights issues or significant M&A on record. The company undertook a successful IPO in 2016.
The Advanced Enzyme Technologies Ltd share price today is ₹295.35 on NSE (ADVENZYMES), as of 25 Oct 2026.
As of 25 Oct 2026, Advanced Enzyme Technologies Ltd share price is ₹295.35, with previous close ₹295.35. Today's range is ₹295.35 to ₹295.35. The 52-week range is ₹246.85 to ₹419.
As of today, Advanced Enzyme Technologies Ltd's market cap is ₹3,402.43 crore (Small Cap).
Advanced Enzyme Technologies Ltd's current P/E ratio is 25.09, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 36.30.
Advanced Enzyme Technologies Ltd's current P/B ratio is 2.02.
Advanced Enzyme Technologies Ltd's current dividend yield is 0.46%. Last dividend of ₹1.00 per share was declared on 14-Feb-2024.
Advanced Enzyme Technologies Ltd's EPS (TTM) is ₹28.58.
Advanced Enzyme Technologies Ltd (AETL) is a leading Indian enzyme manufacturer. It specializes in researching, developing, producing, and marketing over 400 proprietary enzyme products. AETL caters to diverse industries including human nutrition, animal feed, textiles, food & beverages, and biofuels, focusing on sustainable and innovative biotechnology solutions with a significant global footprint.
Advanced Enzyme Technologies Ltd is promoted by Dr. Vasant Rathi and family, holding 43.26% as of 25 Oct 2026.
Advanced Enzyme Technologies Ltd is listed on NSE (ADVENZYMES) and BSE (540025). Its next quarterly results are expected on August 2024 (Q1 FY25).
Adjusted Earnings Per Share (Adjusted EPS)